Healthcare PR shop De Facto Communications has been brought on board to promote the Sheffield-based developer's VenturiOne product.
De Facto has been briefed to reposition Applied Cytometry as an independent, high performance software developer.
It is also rolling out an integrated PR campaign including media relations, search engine optimisation and online marketing activity.
The agency has been charged with initially raising awareness of Applied Cytometry's re-branding from ACS and flagging up its relaunched website.
De Facto co-founder and director Kevin Payne said: 'Primarily we will be targeting people working in stem cells and cancer research. But this new technology will also appeal to anyone who needs fast data analysis.'